Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial (Q38135798)

From Wikidata
Jump to navigation Jump to search
scientific article published on 09 September 2013
edit
Language Label Description Also known as
English
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial
scientific article published on 09 September 2013

    Statements

    Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial (English)
    Igor Bondarenko
    Vladimir Lesovoy
    Boris Y Alekseev
    Cristina Ivanescu
    Andrew Krivoshik
    Brooke Esteves
    Anna Berkenblit
    Thomas E Hutson

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit